![](/img/cover-not-exists.png)
PCN68 BRENTUXIMAB VEDOTIN FOR CONSOLIDATION THERAPY AFTER ASCT IN CD30+ HODGKIN'S LYMPHOMA: A SUSTAINABLE PHARMACEUTICAL EXPENDITURE FOR THE ITALIAN NATIONAL HEALTH SERVICE
Peduto, I., Heiman, F., Morelli, P., Fioravanti, L., Demma, F.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.265
Date:
November, 2019
File:
PDF, 585 KB
2019